CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
Page 2 of 18 · 343 filings